PAVM Past Earnings Q&A
What was the best and worst PAVM past earnings results?
For PAVmed, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
The highest PAVM past earnings result in our data set was -0.080/share posted in Q2 2021, while the lowest was in Q2 2022 when PAVM posted -0.170/share.
The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when PAVM reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at NA of revenue.
There are 24 PAVM past earnings results in our data set.
On this page we presented the PAVM past earnings date information for PAVmed. Reviewing that
PAVM Past Earnings
for the company, we see that the highest past earnings result in our data set was in Q2 2021, when PAVM posted adjusted EPS of -0.080/share. Meanwhile the lowest PAVM past earnings result was in Q2 2022, when PAVM posted adjusted EPS of -0.170/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when PAVM reported 0.00B in revenue, while the smallest revenue quarter was Q2 2022 when PAVM reported NA in revenue.
Any self directed investor doing their due diligence on PAVM or any other given stock can benefit from
researching all of the PAVmed past earnings — and here, we present each quarter's result all together
on one page for easy comparison. Studying this information can help when projecting future earnings, as well
as determining whether the past earnings trajectory justifies the current stock value.
That's why we bring you PastEarnings
.com to make it easy for investors to investigate
PAVmed past earnings, or the past earnings information for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for earnings
surprises history (beat/miss data) as well as next earnings dates for PAVM. Thanks for visiting, and the next
time you need to research PAVM past earnings
or those of another stock, we hope you'll think of our site, as your
go-to past earnings research resource of choice.